Gala Therapeutics

Gala Therapeutics is a medical device company based in San Carlos, California, established in 2015. The company is dedicated to developing innovative technologies aimed at treating pulmonary diseases. Its flagship product, RheOx, is a medical system that utilizes a single-use catheter and an electrosurgical generator to deliver non-thermal energy to the airways. This system specifically targets mucus-producing cells in patients with Chronic Bronchitis, addressing the underlying disease mechanism rather than merely managing symptoms. Gala Therapeutics serves interventional pulmonologists, thoracic surgeons, and other healthcare professionals involved in pulmonary care. The company focuses on creating disease-modifying therapies that enhance survival, quality of life, and clinical outcomes for patients with chronic lung conditions. With support from healthcare-focused venture capital, Gala Therapeutics is expanding its portfolio of technologies to meet the needs of patients suffering from respiratory diseases.

• Employees 8
• Founded 2015
• Annual Revenue $5000000
• Total Funding $118544838